Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-25-014515
Filing Date
2025-02-05
Accepted
2025-02-05 16:21:01
Documents
2
Period of Report
2025-02-03

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 3894
2 EX-24.1 krro-ex24_1.htm EX-24.1 13973
  Complete submission text file 0000950170-25-014515.txt   19446
Mailing Address 60 FIRST STREET 2ND FLOOR, SUITE 250 CAMBRIDGE MA 02141
Business Address 60 FIRST STREET 2ND FLOOR, SUITE 250 CAMBRIDGE MA 02141 617-468-1999
Korro Bio, Inc. (Issuer) CIK: 0001703647 (see all company filings)

EIN.: 472324450 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O KORRO BIO, INC. ONE KENDALL SQUARE, BUILDING 600-700 CAMBRIDGE MA 02139
Business Address
Chappell Todd (Reporting) CIK: 0001997992 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39062 | Film No.: 25593601